Timo Soeterik

78 CHAPTER 4 SUPPLEMENTARY TABLE S2. Patient characteristics of RARP subpopulation included for analysis N (%) Patients 506 Age (mean, SD) 65.8 (6.1) PSA (mean, SD) 11.9 (15.9) Clinical T-stage T1c/T2 ≥T3 470 (93) 36 (7) Risk group (DRE) Low Intermediate High (localized) High (locally advanced) 63 (12) 252 (50) 132 (26) 59 (12) MRI T-stage Organ-confined ≥T3 337 (66) 169 (34) Pathological T-stage T2 ≥T3a 272 (54) 234 (46) SUPPLEMENTARY TABLE S3. Risk group migration patterns in patients undergoing mpMRI in the RARP subset Risk group based on MRI Low N (%) Intermediate N (%) High (localized) N (%) High (locally advanced) N (%) Total N (%) Based on DRE Low 46 (73) 0 (0) 6 (10) 11 (17) 63 (13) Intermediate 0 (0) 144 (57) 33 (13) 75 (30) 252 (50) High (localized) 0 (0) 3 (2) 83 (63) 46 (35) 132 (26) High (locally advanced) 0 (0) 3 (5) 5 (9) 51 (86) 59 (12) 46 (9) 150 (30) 127 (25) 183 (36) 506 (100)